Geron reported $-28117000 in Net Income for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Amgen AMGN:US USD 1.62B 527M
Bio Techne TECH:US USD 50M 39.55M
Cti Biopharma CTIC:US USD -15705000 6.95M
Cytokinetics CYTK:US USD -142310000 122.49M
Esperion Therapeutics ESPR:US USD -55117000 11.21M
Exelixis EXEL:US USD 73.21M 2.54M
Genmab GEN:DC DKK 2.58B 691M
Gilead Sciences GILD:US USD 1.64B 149M
Macrogenics MGNX:US USD -24813000 16.49M
Novartis NOVN:VX USD 1.57B 121M
Pain Therapeutics PTIE:US USD -20257000 929K
Seattle Genetics SGEN:US USD -190816000 55.99M
YTE INCY:US USD 112.78M 48.66M